Completed
A Phase 2 Study Of The Efficacy And Safety Of SU011248 In Patients With Metastatic Breast Cancer
What is being tested
Data Collection
Who is being recruted
Breast Diseases+2
+ Breast Neoplasms
+ Neoplasms
Over 18 Years
How is the trial designed
Treatment Study
Phase 2
Interventional
Study Start: March 2004
Summary
Principal SponsorPfizer
Last updated: January 13, 2026
Sourced from a government-validated database.Claim as a partner
Study start date: March 1, 2004
Actual date on which the first participant was enrolled.Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.
Principal SponsorPfizer
Last updated: January 13, 2026
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
64 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Breast DiseasesBreast NeoplasmsNeoplasmsNeoplasms by SiteSkin Diseases
Criteria
Inclusion Criteria: * Anthracycline and taxane-refractory or intolerant metastatic breast cancer * Female Exclusion Criteria: * Prior treatment with 3 or greater regimens of chemotherapy in the advanced/metastatic disease setting beyond those containing anthracyclines/taxanes.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 10 locations
Suspended
Suspended
Pfizer Investigational Site
Los Angeles, United StatesSuspended
Pfizer Investigational Site
San Francisco, United StatesSuspended
Pfizer Investigational Site
Aurora, United StatesCompleted10 Study Centers